NEW YORK (GenomeWeb News) — Compugen today reported zero revenues for the third quarter as net losses declined 30 percent.
 
Receipts for the three months ended Sept. 30, 2005, were $95,000, Compugen said.
 
R&D spending for the quarter declined 26 percent to $1.7 million from $2.3 million in 2005.
 
Compugen said net losses in the quarter declined 30 percent to $2.5 million  percent from $3.6 million year over year.  
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.